Thu, Oct 30, 2014, 12:26 PM EDT - U.S. Markets close in 3 hrs 34 mins

Recent

% | $
Quotes you view appear here for quick access.

Alexza Pharmaceuticals Inc. Message Board

hopedoesntcount 5 posts  |  Last Activity: Oct 3, 2014 11:34 AM Member since: May 15, 2013
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Many on this board are expecting the next MNKD 10Q to provide transparency on the exact $'s and %'s associated with milestones and other financial details in the Sanofi agreement. I also would like to learn those details, but most companies similarly situated with a marketing agreement such as Mannkind do not publicly disclose that detailed information. Mannkind's next 10Q filing should include the Sanofi agreement as an exhibit but the $'s and %'s of most forecasting value to investors will be redacted and instead direct you to a footnote that reads something like this:
    *** INDICATES MATERIAL THAT WAS OMITTED AND FOR WHICH CONFIDENTIAL TREATMENT WAS REQUESTED. ALL SUCH OMITTED MATERIAL WAS FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24b-2 PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED.

    Giving everyone a heads-up now so expectations can be tempered and to avoid at least some disappointment that could cause further erosion of pps when those financial details are not disclosed in Mannkind's SEC filing.

  • hopedoesntcount hopedoesntcount Sep 24, 2014 9:40 AM Flag

    The possible lawsuit complaint will demand that Defendants, King and other culpable members of the board ("cronies of the board"), return alleged misappropriations to the company. Assuming the suit is successful, if all defendants sold their stock the possible cash amount returned to the company could be in the vicinity of $3,000,000. Defendants still holding shares will return stock to the Alexza stock treasury.

  • hopedoesntcount by hopedoesntcount Sep 23, 2014 7:58 PM Flag

    Today was the 15 year historical low for Alexza.

    Thomas King is a disastrous, self-serving and arrogant CEO (he is also an obnoxious @!%$& in person that comes across treating shareholders as the enemy). He must go! There were and are many things King could do to realize the potential of Staccato. But he is incompetent and a strategic dunce. Send emails to fund managers holding ALXA to replace King and his cronies.

  • According to the law firm investigating Alexza, the Board of Directors, of course including King, gave themselves about 800,000 shares of stock above what shareholders approved.

    Tom King must go. Although retail stockholders have little power to influence his ouster, I for one would support any movement to solicit the institutions to push incompetent Thomas King, and his cronies on the board, out of the company.

  • Looks like Jason Napodano took Atlnsider to the woodshed on who's the better analyst.

ALXA
2.5425-0.1075(-4.06%)12:20 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.